INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis
USA - NYSE:INSP - US4577301090 - Common Stock
83.4 USD
+3.4 (+4.25%)
83.4 USD
0 (0%)
Taking everything into account, INSP scores 6 out of 10 in our fundamental rating. INSP was compared to 191 industry peers in the Health Care Equipment & Supplies industry. INSP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. INSP is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make INSP suitable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year INSP was profitable.
In the past year INSP had a positive cash flow from operations.
INSP had negative earnings in 4 of the past 5 years.
In multiple years INSP reported negative operating cash flow during the last 5 years.
1.2 Ratios
INSP has a better Return On Assets (6.62%) than 86.39% of its industry peers.
The Return On Equity of INSP (7.84%) is better than 81.15% of its industry peers.
INSP has a better Return On Invested Capital (5.35%) than 78.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.62% | ||
| ROE | 7.84% | ||
| ROIC | 5.35% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of INSP (6.17%) is better than 77.49% of its industry peers.
Looking at the Operating Margin, with a value of 4.81%, INSP is in the better half of the industry, outperforming 69.63% of the companies in the same industry.
Looking at the Gross Margin, with a value of 84.47%, INSP belongs to the top of the industry, outperforming 94.24% of the companies in the same industry.
INSP's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.81% | ||
| PM (TTM) | 6.17% | ||
| GM | 84.47% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
INSP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for INSP has been increased compared to 1 year ago.
Compared to 5 years ago, INSP has more shares outstanding
INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 12.86 indicates that INSP is not in any danger for bankruptcy at the moment.
INSP has a better Altman-Z score (12.86) than 93.19% of its industry peers.
INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 12.86 |
ROIC/WACC0.61
WACC8.7%
2.3 Liquidity
INSP has a Current Ratio of 6.14. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
INSP has a better Current ratio (6.14) than 81.68% of its industry peers.
INSP has a Quick Ratio of 4.84. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
INSP's Quick ratio of 4.84 is amongst the best of the industry. INSP outperforms 80.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.14 | ||
| Quick Ratio | 4.84 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 1177.78% over the past year.
INSP shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.05%.
INSP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 57.78% yearly.
EPS 1Y (TTM)1177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.63%
Revenue 1Y (TTM)22.05%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.82%
3.2 Future
INSP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.47% yearly.
Based on estimates for the next years, INSP will show a quite strong growth in Revenue. The Revenue will grow by 14.28% on average per year.
EPS Next Y-70.47%
EPS Next 2Y-5%
EPS Next 3Y14.99%
EPS Next 5Y26.47%
Revenue Next Year13.1%
Revenue Next 2Y13.73%
Revenue Next 3Y14.08%
Revenue Next 5Y14.28%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 36.26, the valuation of INSP can be described as expensive.
Based on the Price/Earnings ratio, INSP is valued a bit cheaper than 72.25% of the companies in the same industry.
INSP is valuated rather expensively when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 53.42 indicates a quite expensive valuation of INSP.
Based on the Price/Forward Earnings ratio, INSP is valued a bit cheaper than the industry average as 68.06% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.88. INSP is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.26 | ||
| Fwd PE | 53.42 |
4.2 Price Multiples
70.16% of the companies in the same industry are more expensive than INSP, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of INSP indicates a rather cheap valuation: INSP is cheaper than 81.68% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.01 | ||
| EV/EBITDA | 35.85 |
4.3 Compensation for Growth
INSP's earnings are expected to grow with 14.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5%
EPS Next 3Y14.99%
5. Dividend
5.1 Amount
No dividends for INSP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
83.4
+3.4 (+4.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners114.52%
Inst Owner Change-1.82%
Ins Owners0.94%
Ins Owner Change0.31%
Market Cap2.47B
Analysts75.38
Price Target148.19 (77.69%)
Short Float %8.74%
Short Ratio2.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)127.01%
Min EPS beat(2)114.53%
Max EPS beat(2)139.49%
EPS beat(4)4
Avg EPS beat(4)247.35%
Min EPS beat(4)54.07%
Max EPS beat(4)681.29%
EPS beat(8)8
Avg EPS beat(8)257.08%
EPS beat(12)12
Avg EPS beat(12)187.32%
EPS beat(16)16
Avg EPS beat(16)150.49%
Revenue beat(2)1
Avg Revenue beat(2)0.22%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)1.13%
Revenue beat(4)2
Avg Revenue beat(4)0.1%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)-0.06%
Revenue beat(12)8
Avg Revenue beat(12)2.61%
Revenue beat(16)12
Avg Revenue beat(16)3.81%
PT rev (1m)-16.71%
PT rev (3m)-32.96%
EPS NQ rev (1m)-188.29%
EPS NQ rev (3m)-135.88%
EPS NY rev (1m)-77.9%
EPS NY rev (3m)-77.9%
Revenue NQ rev (1m)-0.69%
Revenue NQ rev (3m)-7.99%
Revenue NY rev (1m)-4.73%
Revenue NY rev (3m)-4.73%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.26 | ||
| Fwd PE | 53.42 | ||
| P/S | 2.86 | ||
| P/FCF | 29.01 | ||
| P/OCF | 21 | ||
| P/B | 3.64 | ||
| P/tB | 3.64 | ||
| EV/EBITDA | 35.85 |
EPS(TTM)2.3
EY2.76%
EPS(NY)1.56
Fwd EY1.87%
FCF(TTM)2.87
FCFY3.45%
OCF(TTM)3.97
OCFY4.76%
SpS29.13
BVpS22.92
TBVpS22.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.62% | ||
| ROE | 7.84% | ||
| ROCE | 5.84% | ||
| ROIC | 5.35% | ||
| ROICexc | 9.29% | ||
| ROICexgc | 9.29% | ||
| OM | 4.81% | ||
| PM (TTM) | 6.17% | ||
| GM | 84.47% | ||
| FCFM | 9.87% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
F-Score7
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 300.74% | ||
| Cap/Sales | 3.77% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 225.05% | ||
| Profit Quality | 160.03% | ||
| Current Ratio | 6.14 | ||
| Quick Ratio | 4.84 | ||
| Altman-Z | 12.86 |
F-Score7
WACC8.7%
ROIC/WACC0.61
Cap/Depr(3y)638.93%
Cap/Depr(5y)518.49%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.63%
EPS Next Y-70.47%
EPS Next 2Y-5%
EPS Next 3Y14.99%
EPS Next 5Y26.47%
Revenue 1Y (TTM)22.05%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.82%
Revenue Next Year13.1%
Revenue Next 2Y13.73%
Revenue Next 3Y14.08%
Revenue Next 5Y14.28%
EBIT growth 1Y389.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year687.25%
EBIT Next 3Y123.87%
EBIT Next 5Y79.05%
FCF growth 1Y348.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y245.22%
OCF growth 3YN/A
OCF growth 5YN/A